| Brian Schlidt, MD | |
|
1541 Diamond Dr, Casper, WY 82601-6247 | |
| (307) 217-8799 | |
| Not Available |
| Full Name | Brian Schlidt |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1541 Diamond Dr, Casper, Wyoming |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386208841 | NPI | - | NPPES |
| Entity Name | 307 Psychiatry |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972388981 PECOS PAC ID: 7618322850 Enrollment ID: O20231009002098 |
News Archive
Weight loss and control of blood sugar can reduce the risk of complications in patients with diabetes but this is difficult for many to achieve. A University of California, San Diego School of Medicine randomized controlled trial of obese adults with type 2 diabetes suggests that participants enrolled in a community-based structured weight loss program are able to shed more pounds, improve blood sugar control and reduce or eliminate insulin use and other medications compared to a control group.
The Female Health Company announced that it has fulfilled an order for 3.5 million FC2 Female Condoms to be distributed for HIV/AIDS prevention to attendees at the 2010 World Cup. The 2010 World Cup will take place in The Republic of South Africa from June 11, 2010 to July 11, 2010.
Fluidigm Corporation today introduced its reusable FR48.48 Dynamic Array™ integrated fluidic circuit (IFC) - the world's first reusable bio-chip for the SNP genotyping market. This chip begins a new era of ultra-low cost, high sample throughput SNP genotyping and marks the beginning of Fluidigm's drive toward one-penny-per-data point.
Janssen Scientific Affairs, LLC today announced the launch of JanssenMD, a new online scientific resource for U.S. healthcare professionals seeking instant access to current information about Janssen products marketed in the U.S. The web-based application is designed for use on desktops, tablets, and smartphones and can be accessed at www.janssenMD.com.
Nektar Therapeutics today announced that new Phase 2 clinical data for NKTR-102, Nektar's lead oncology candidate being evaluated in multiple cancer indications, have been selected for presentation at the 47th Annual Meeting of the American Society of Clinical Oncology being held June 3-7, 2011 in Chicago, Illinois.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian Schlidt, MD 2961 Custer Ave, Billings, MT 59102-4522 Ph: (307) 217-8799 | Brian Schlidt, MD 1541 Diamond Dr, Casper, WY 82601-6247 Ph: (307) 217-8799 |
News Archive
Weight loss and control of blood sugar can reduce the risk of complications in patients with diabetes but this is difficult for many to achieve. A University of California, San Diego School of Medicine randomized controlled trial of obese adults with type 2 diabetes suggests that participants enrolled in a community-based structured weight loss program are able to shed more pounds, improve blood sugar control and reduce or eliminate insulin use and other medications compared to a control group.
The Female Health Company announced that it has fulfilled an order for 3.5 million FC2 Female Condoms to be distributed for HIV/AIDS prevention to attendees at the 2010 World Cup. The 2010 World Cup will take place in The Republic of South Africa from June 11, 2010 to July 11, 2010.
Fluidigm Corporation today introduced its reusable FR48.48 Dynamic Array™ integrated fluidic circuit (IFC) - the world's first reusable bio-chip for the SNP genotyping market. This chip begins a new era of ultra-low cost, high sample throughput SNP genotyping and marks the beginning of Fluidigm's drive toward one-penny-per-data point.
Janssen Scientific Affairs, LLC today announced the launch of JanssenMD, a new online scientific resource for U.S. healthcare professionals seeking instant access to current information about Janssen products marketed in the U.S. The web-based application is designed for use on desktops, tablets, and smartphones and can be accessed at www.janssenMD.com.
Nektar Therapeutics today announced that new Phase 2 clinical data for NKTR-102, Nektar's lead oncology candidate being evaluated in multiple cancer indications, have been selected for presentation at the 47th Annual Meeting of the American Society of Clinical Oncology being held June 3-7, 2011 in Chicago, Illinois.
› Verified 8 days ago
Dr. David B Wheeler, MD PHD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1020 East 2nd Street, Ste 100, Casper, WY 82601 Phone: 307-265-4343 Fax: 307-234-6339 | |
Frank Delreal, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1430 Wilkins Cir, Casper, WY 82601 Phone: 307-237-9583 Fax: 307-265-7277 | |
Dominick Jacob Trombetta, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2521 E 15th St, Casper, WY 82609 Phone: 307-237-7444 Fax: 307-237-2166 | |
Mark D. Vuolo, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 300 S Wolcott St, Suite 330, Casper, WY 82601 Phone: 307-266-6244 | |
Dr. David Morgan Martorano, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2521 E 15th St, Casper, WY 82609 Phone: 307-237-7444 | |
Dr. Larry D Plemmons, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1522 E A St, Casper, WY 82601 Phone: 307-233-6000 Fax: 307-472-3308 |